动脉样板中的新血管化:临床影响,检测和预防策略
Long Zhang1, Chancui Deng2, Sha Wang1
1Department of Cardiology, Zunyi Medical University, 563003 Zunyi, Guizhou, China.
Reviews in cardiovascular medicine
|August 8, 2025
概括
动脉硬性斑块中的新血管化表明脆弱性和破裂风险. 早期发现和干预策略对于预防心血管事件至关重要.
科学领域:
- 心血管医学 心血管医学
- 病理学 病理学 病理学
- 医疗成像医学成像
背景情况:
- 动脉样硬化心血管疾病是一个日益严重的全球健康问题.
- 动脉硬性斑块破裂是心血管不良事件的主要原因之一.
- 斑块内的新血管化是斑块脆弱性的关键指标.
研究的目的:
- 审查新血管化的动脉样硬化斑块的形成机制.
- 讨论斑块新血管化的临床意义.
- 概述新血管化的动脉样硬化斑块的检测技术和预防策略.
主要方法:
- 关于斑块新血管化的文献综述.
- 形成机制的分析.
- 临床意义和检测方法的综合.
主要成果:
- 新血管化有助于斑块的不稳定性和破裂.
- 早期检测新血管化的允许及时干预.
- 各种成像技术可以检测斑块新血管化.
结论:
- 了解新血管化对于治疗动脉样硬化的疾病至关重要.
- 针对新血管化的治疗提供了潜在的治疗策略.
- 检测和预防的综合方法至关重要.
更多相关视频
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
39
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
39
Atherosclerosis I: Introduction
85
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
85
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Coronary Artery Disease II: Pathophysiology
36
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
36
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119


